M. Ancelin and K. Ritchie, Lifelong Endocrine Fluctuations and Related Cognitive Disorders, Current Pharmaceutical Design, vol.11, issue.32
DOI : 10.2174/138161205774913228

URL : https://hal.archives-ouvertes.fr/inserm-00243083

B. Sherwin and J. Henry, Brain aging modulates the neuroprotective effects of estrogen on selective aspects of cognition in women: A critical review, Frontiers in Neuroendocrinology, vol.29, issue.1, pp.88-113, 2008.
DOI : 10.1016/j.yfrne.2007.08.002

B. Sherwin, Estrogen and Cognitive Functioning in Women, Endocrine Reviews, vol.24, issue.2, pp.133-151, 2003.
DOI : 10.1210/er.2001-0016

J. Ryan, J. Scali, I. Carriere, K. Ritchie, and M. Ancelin, Hormonal treatment, mild cognitive impairment and Alzheimer's disease, International Psychogeriatrics, vol.273, issue.01, pp.47-56, 2008.
DOI : 10.1097/00002093-200304000-00002

V. Henderson and B. Sherwin, Surgical versus natural menopause, Menopause, vol.14, issue.Suppl. 1
DOI : 10.1097/gme.0b013e31803df49c

3. The and . Group, Vascular factors and risk of dementia: Design of the three city study and baseline characteristics of the study population, Neuroepidemiology, vol.22, pp.316-325, 2003.

C. Dufouil, F. Richard, and N. Fievet, APOE genotype, cholesterol level, lipid-lowering treatment, and dementia: The Three-City Study, Neurology, vol.64, issue.9, pp.1531-1538, 2005.
DOI : 10.1212/01.WNL.0000160114.42643.31

URL : https://hal.archives-ouvertes.fr/inserm-00175952

J. Ryan, I. Carriere, J. Scali, K. Ritchie, and M. Ancelin, Life-time estrogen exposure and cognitive functioning in later life, Psychoneuroendocrinology, vol.34, issue.2, pp.287-298, 2009.
DOI : 10.1016/j.psyneuen.2008.09.008

URL : https://hal.archives-ouvertes.fr/inserm-00355040

A. Psychiatric-association, L. Joly, P. Alioum, A. Dartigues, and J. , Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) Washington, DC: American Psychiatric Association Modelling age-specific risk: application to dementia, Stat Med, vol.17, pp.1973-1988, 1994.

S. Rapp, M. Espeland, and S. Shumaker, Effect of Estrogen Plus Progestin on Global Cognitive Function in Postmenopausal Women, JAMA, vol.289, issue.20, pp.2663-2672, 2003.
DOI : 10.1001/jama.289.20.2663

S. Shumaker, C. Legault, and L. Thal, Estrogen Plus Progestin and the Incidence of Dementia and Mild Cognitive Impairment in Postmenopausal Women, JAMA, vol.289, issue.20, pp.2651-2662, 2003.
DOI : 10.1001/jama.289.20.2651

S. Resnick, P. Maki, and S. Rapp, Effects of Combination Estrogen Plus Progestin Hormone Treatment on Cognition and Affect, The Journal of Clinical Endocrinology & Metabolism, vol.91, issue.5, pp.1802-1810, 2006.
DOI : 10.1210/jc.2005-2097

E. Hogervorst, J. Williams, M. Budge, W. Riedel, and J. Jolles, The nature of the effect of female gonadal hormone replacement therapy on cognitive function in post-menopausal women: a meta-analysis, Neuroscience, vol.101, issue.3, pp.485-512, 2000.
DOI : 10.1016/S0306-4522(00)00410-3

E. Leblanc, J. Janowsky, B. Chan, and H. Nelson, Hormone Replacement Therapy and Cognition, JAMA, vol.285, issue.11, pp.1489-1499, 2001.
DOI : 10.1001/jama.285.11.1489

S. Duff, E. Hampson, Y. Smith, B. Giordani, R. Lajiness-o-'neill et al., A beneficial effect of estrogen on working memory in postmenopausal women taking hormone replacement therapy Long-term estrogen replacement is associated with improved nonverbal memory and attentional measures in postmenopausal women, Horm Behav Fertil Steril, vol.3876, issue.17, pp.262-2761101, 2000.

E. Barrett-connor and D. Kritz-silverstein, Estrogen Replacement Therapy and Cognitive Function in Older Women, JAMA: The Journal of the American Medical Association, vol.269, issue.20, pp.2637-2641, 1993.
DOI : 10.1001/jama.1993.03500200051032

F. Grodstein, J. Chen, and D. Pollen, Postmenopausal hormone therapy and cognitive function in healthy older women Could transdermal estradiol + progesterone be a safer postmenopausal HRT? A review, J Am Geriatr Soc Maturitas, vol.4860, issue.20, pp.746-752185, 2000.

M. Schumacher, R. Guennoun, and A. Ghoumari, Novel Perspectives for Progesterone in Hormone Replacement Therapy, with Special Reference to the Nervous System, Endocrine Reviews, vol.28, issue.4, pp.387-439, 2007.
DOI : 10.1210/er.2006-0050

V. Henderson, K. Benke, R. Green, L. Cupples, and L. Farrer, Postmenopausal hormone therapy and Alzheimer's disease risk: interaction with age, Journal of Neurology, Neurosurgery & Psychiatry, vol.76, issue.1, pp.103-105, 2005.
DOI : 10.1136/jnnp.2003.024927

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1739309

Y. Bagger, L. Tanko, P. Alexandersen, G. Qin, and C. Christiansen, Early postmenopausal hormone therapy may prevent cognitive impairment later in life, Menopause, vol.12, issue.1, pp.12-17, 2005.
DOI : 10.1097/00042192-200512010-00005

A. Maclennan, V. Henderson, and B. Paine, Hormone therapy, timing of initiation, and cognition in women aged older than 60 years: the REMEMBER pilot study, Menopause, vol.13, issue.1
DOI : 10.1097/01.gme.0000191204.38664.61

A. Maclennan, V. Henderson, and B. Paine, Hormone therapy, timing of initiation, and cognition in women aged older than 60 years: the REMEMBER pilot study, Menopause, vol.13, issue.1, pp.28-36, 2006.
DOI : 10.1097/01.gme.0000191204.38664.61

W. Rocca, J. Bower, and D. Maraganore, Increased risk of cognitive impairment or dementia in women who underwent oophorectomy before menopause, Neurology, vol.69, issue.11, pp.1074-1083, 2007.
DOI : 10.1212/01.wnl.0000276984.19542.e6

C. Kawas, S. Resnick, and A. Morrison, A Prospective Study of Estrogen Replacement Therapy and the Risk of Developing Alzheimer's Disease, Obstetrical & Gynecological Survey, vol.52, issue.11, pp.1517-1521, 1997.
DOI : 10.1097/00006254-199711000-00020

M. Tang, D. Jacobs, and Y. Stern, Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease, The Lancet, vol.348, issue.9025, pp.429-432, 1996.
DOI : 10.1016/S0140-6736(96)03356-9

P. Zandi, M. Carlson, and B. Plassman, Hormone Replacement Therapy and Incidence of Alzheimer Disease in Older Women<SUBTITLE>The Cache County Study</SUBTITLE>, JAMA, vol.288, issue.17, pp.2123-2129, 2002.
DOI : 10.1001/jama.288.17.2123

D. Petitti, V. Crooks, V. Chiu, J. Buckwalter, and H. Chui, Incidence of Dementia in Long-term Hormone Users, American Journal of Epidemiology, vol.167, issue.6, pp.692-700, 2008.
DOI : 10.1093/aje/kwm362

S. Shumaker, C. Legault, and L. Kuller, Conjugated Equine Estrogens and Incidence of Probable Dementia and Mild Cognitive Impairment in Postmenopausal Women<SUBTITLE>Women's Health Initiative Memory Study</SUBTITLE>, JAMA, vol.291, issue.24, pp.2947-2958, 2004.
DOI : 10.1001/jama.291.24.2947

G. Rippon, M. Tang, J. Lee, R. Lantigua, M. Medrano et al., Familial Alzheimer disease in Latinos: Interaction between APOE, stroke, and estrogen replacement, Neurology, vol.66, issue.1, pp.35-40, 2006.
DOI : 10.1212/01.wnl.0000191300.38571.3e

S. Yun, K. Park, and S. Kwon, Estradiol enhances long term potentiation in hippocampal slices from aged apoE4-TR mice, Hippocampus, vol.82, issue.12, pp.1153-1157, 2007.
DOI : 10.1002/hipo.20357

K. Yaffe, M. Haan, A. Byers, C. Tangen, and L. Kuller, Estrogen use, APOE, and cognitive decline: Evidence of gene-environment interaction, Neurology, vol.54, issue.10, pp.1949-1954, 2000.
DOI : 10.1212/WNL.54.10.1949

M. Burkhardt, J. Foster, and S. Laws, Oestrogen replacement therapy may improve memory functioning in the absence of APOE ??4, Journal of Alzheimer's Disease, vol.6, issue.3, pp.221-228, 2004.
DOI : 10.3233/JAD-2004-6302

M. Folstein, S. Folstein, and P. Mchugh, ???Mini-mental state???, Journal of Psychiatric Research, vol.12, issue.3, pp.189-198, 1975.
DOI : 10.1016/0022-3956(75)90026-6

B. Isaacs and A. Kennie, The Set Test as an Aid to the Detection of Dementia in Old People, The British Journal of Psychiatry, vol.123, issue.4
DOI : 10.1192/bjp.123.4.467

A. Benton, Manuel pour l'application du test de retention visuelle. Applications cliniques et experimentales, 1965.

B. Dubois, L'epreuve des cinq mots, Neurology Psychiatrie Geriatr, vol.1, pp.40-42, 2001.

R. Reitan, Validity of the Trail Making Test as an indicator of organic brain damage